Fortney Kristen
Chief Executive Officer
Fortney Kristen has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 15, 2026.
On the most recent filing, Fortney Kristen is listed as Chief Executive Officer at BioAge Labs, Inc. Inside the rolling window, Fortney Kristen reported no open-market purchases and 1 open-market sale totaling $4.2M in BIOA.
Companies traded
Other insiders at BIOA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fortney Kristen made?
Fortney Kristen has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Fortney Kristen trade?
Fortney Kristen has filed SEC Form 4 disclosures for 1 company, including BIOA.
When was Fortney Kristen's most recent SEC Form 4 filing?
Fortney Kristen's most recent SEC Form 4 filing on Tracefour is dated Jan 15, 2026.
What is Fortney Kristen's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Fortney Kristen is listed as Chief Executive Officer.
What is Fortney Kristen's total buy and sell value in the current window?
Inside the rolling retention window, Fortney Kristen bought $0 and sold $4.2M based on SEC Form 4 filings.
What was Fortney Kristen's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 233,107 BIOA shares on 2026-01-13, worth $4.2M, per SEC Form 4 filings.